Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

Lifearc has announced a collaboration with Neuropeutics Inc. to develop a new small molecule for the treatment of motor neuron disease (MND), or amyotrophic lateral sclerosis (ALS). Neuropeutics and ...

This is the latest venture for Amylyx into the ALS field after its previous therapy Relyvrio was pulled from the market in ...

Multiple sclerosis (MS) hip pain and knee soreness are very common problems. Joint issues are usually due to a nerve-related or muscle-related manifestation of MS rather than degeneration of cartilage ...

While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.

When it comes to the outlook for multiple sclerosis (MS), there’s both good news and bad news. Although MS isn’t fatal, there’s currently no cure — MS is a chronic condition. But many ...

Introduction: T regulatory cells (Tregs) inversely correlate with disease progression in Amyotrophic Lateral Sclerosis (ALS) and fast-progressing ALS patients have been reported to exhibit ...

Early signs of multiple sclerosis can include blurry vision, muscle weakness, dizziness and fatigue, and unusual tingling or pain sensations. These early warning signs occur because of damage to the ...

Correspondence to Dr Hanne Marie Bøe Lunde, Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Jonas Lies vei 65, Bergen 5021, Norway; ...